Medtronic has issued a recall for several aortic root cannula devices due to a potential safety risk that could cause loose ...
5h
Zacks Investment Research on MSNMedtronic (MDT) Advances But Underperforms Market: Key FactsMedtronic (MDT) closed at $88.86 in the latest trading session, marking a +0.42% move from the prior day. This change lagged the S&P 500's 0.67% gain on the day. Meanwhile, the Dow experienced a rise ...
Patients with severe aortic stenosis had comparable rates of death or disabling stroke, but the lead investigator cautions ...
A new report ranked the country’s longevity hotspots based on factors such as gender, family, volunteering, religious ...
Medtronic has inked a neurovascular partnership with Methinks AI, a Barcelona, Spain-based developer of programs to detect ...
Medtronic, Abbott and Boston Scientific provided updates on their devices used in heart valve disease treatment at the event.
Explore more
Researchers found that at five years, patients with severe aortic stenosis who were treated with either TAVR or surgery had comparable rates of all-cause mortality or disabling stroke.
Medtronic (NYSE: MDT) recently announced a partnership with Methinks AI to enhance stroke treatment in a number of ...
Abbott’s pulse field ablation system competes with products from Medtronic and Boston Scientific, which also have large ...
Shares of Medtronic PLC MDT shed 1.52% to $88.49 Tuesday, on what proved to be an all-around mixed trading session for the ...
Here are two blue-chip value stocks I'm steadily accumulating right now. What makes this discount particularly compelling is ...
1d
Medical Device Network on MSNMedtronic reports late-breaking data from TAVR system trial for aortic stenosisMedtronic has reported late-breaking data from the randomised Evolut Low Risk Trial’s five-year outcomes of the Evolut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results